This is inconsistent with a recent report showing reduced serum Ang (1–7) levels, rather than reduced ACE-2 activity, in senescence-accelerated mouse prone 8, a mouse model of sporadic AD (involving overexpression of APP). Here, ANGPT1 is linked to Alzheimer disease.